Search results
Parkinson's: New treatment may help reduce motor symptoms
Medical News Today· 6 hours agoPrasinezumab, a monoclonal antibody designed to target protein clumps in the brains of people with...
Are Monoclonal Antibodies the Future of Long COVID Treatments?
Technology Networks· 3 days agoThe bulk of long COVID research carried out over the past four years has attempted to understand the...
Monoclonal Antibody Slows Rapid Motor Decline in Parkinson's - Neuroscience News
Neuroscience News· 1 week agoWhile there are currently no disease-modifying treatments for PD, prasinezumab offers a potential...
OSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of...
Morningstar· 1 week agoOSE Immunotherapeutics’ Global License to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation Becomes Effective NANTES, France ...
Dog Doo Drop Raises Eyebrows For Parvovirus Awareness
MediaPost· 2 days agoFake dog poop is dropping across the country starting Tuesday, as Elanco Animal Health calls attention to how parvovirus, a very contagious and deadly disease, gets spread from canine to canine ...
Heartburn drugs taken by millions 'increase the risk of agonising brain attacks'
The US Sun· 21 hours agoOften the only way to get rid of a migraine is to take painkillers and sleep it off. There are many...
Florida clinic plans to treat 10,000 Alzheimer’s patients a year. Look at what’s coming
Miami Herald via Yahoo News· 3 hours agoHow Leqembi works Leqembi, produced and marketed by Biogen and Eisai, is a monoclonal antibody given...
Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation...
Benzinga· 21 hours agoBOSTON, April 24, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer
Epitope Binning Powered By LENSai TM Technology Can Analyze Over 5,000 Sequences With No Physical...
Digital Journal· 3 days agoThe platform is now integrating epitope binning into its formulas. Epitope binning is a method used to compare and categorize a collection of monoclonal antibodies that are designed to target ...
GV20 Therapeutics Announces Publication in Cell Highlighting the Discovery of IGSF8 as an Innate...
CBS 47 Fresno· 1 day agoGV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and cancer biology to create next-generation antibody therapeutics, today announced the ...
